Academic literature on the topic 'CIN 2'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'CIN 2.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "CIN 2"
Crum, Christopher P. "Laboratory Management of CIN 2." American Journal of Clinical Pathology 130, no. 2 (August 2008): 162–64. http://dx.doi.org/10.1309/gcvb5c4kfv7tfc7f.
Full textCorona Gutierrez, Carlos Manuel, Alberto Tinoco, Tania Navarro, Mario López Contreras, Roberto Risco Cortes, Patricia Calzado, Lise Reyes, et al. "Therapeutic Vaccination with MVA E2 Can Eliminate Precancerous Lesions (CIN 1, CIN 2, and CIN 3) Associated with Infection by Oncogenic Human Papillomavirus." Human Gene Therapy 15, no. 5 (May 2004): 421–31. http://dx.doi.org/10.1089/10430340460745757.
Full textMastutik, Gondo, Rahmi Alia, Alphania Rahniayu, Anny Setijo Rahaju, and Renny I’tishom. "Human pappilomavirus genotype in cervical tissue of patients with Cervical Intraepithelial Neoplasia (CIN) 1, CIN 2, and CIN 3." Majalah Obstetri & Ginekologi 24, no. 3 (June 21, 2017): 74. http://dx.doi.org/10.20473/mog.v24i3.4568.
Full textMastutik, Gondo, Rahmi Alia, Alphania Rahniayu, Anny Setijo Rahaju, Renny I’tishom, and Suhartono Taat Putra. "Human pappilomavirus genotype in cervical tissue of patients with Cervical Intraepithelial Neoplasia (CIN) 1, CIN 2, and CIN 3." Majalah Obstetri & Ginekologi 24, no. 3 (March 31, 2018): 74. http://dx.doi.org/10.20473/mog.v24i32016.74-78.
Full textKatki, Hormuzd A., Mark Schiffman, Philip E. Castle, Barbara Fetterman, Nancy E. Poitras, Thomas Lorey, Li C. Cheung, Tina Raine-Bennett, Julia C. Gage, and Walter K. Kinney. "Five-Year Risk of Recurrence After Treatment of CIN 2, CIN 3, or AIS." Journal of Lower Genital Tract Disease 17 (April 2013): S78—S84. http://dx.doi.org/10.1097/lgt.0b013e31828543c5.
Full textDemarco, Maria, Thomas S. Lorey, Barbara Fetterman, Li C. Cheung, Richard S. Guido, Nicolas Wentzensen, Walter K. Kinney, et al. "Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status." Journal of Lower Genital Tract Disease 21, no. 4 (October 2017): 261–67. http://dx.doi.org/10.1097/lgt.0000000000000343.
Full textTowler, Bernadette P., Les M. Irwig, and Julia M. Shelley. "The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities." Medical Journal of Australia 159, no. 8 (October 1993): 523–28. http://dx.doi.org/10.5694/j.1326-5377.1993.tb138005.x.
Full textWindrum, Graham. "The adequacy of management of women with CIN 2 and CIN 3 Pap smear abnormalities." Medical Journal of Australia 160, no. 3 (February 1994): 165–66. http://dx.doi.org/10.5694/j.1326-5377.1994.tb126581.x.
Full textCarcopino, X., C. Muszynski, J. L. Mergui, J. Gondry, and L. Boubli. "La CIN 2 merite-t-elle la même prise en charge que la CIN 3 ?" Gynécologie Obstétrique & Fertilité 39, no. 2 (February 2011): 94–99. http://dx.doi.org/10.1016/j.gyobfe.2010.11.001.
Full textSykes, Peter, Carrie Innes, Dianne Harker, Martin Whitehead, Rachael van der Griend, Beverley Lawton, Merilyn Hibma, et al. "Observational Management of CIN 2 in Young Women." Journal of Lower Genital Tract Disease 20, no. 4 (October 2016): 343–47. http://dx.doi.org/10.1097/lgt.0000000000000244.
Full textDissertations / Theses on the topic "CIN 2"
Genovès, Gonzàlez Jordi. "Evolució de les lesions CIN-2 segons la P16 i el Ki-67." Doctoral thesis, Universitat Autònoma de Barcelona, 2018. http://hdl.handle.net/10803/666934.
Full textIntraepithelial cervical lesions are caused by persistent infection of a high risk human papilloma (HPV). If they are not resolved, they can grow and cause cervical cancer. CIN-2 lesions are an intermediate degree, with a regression rate of 40% (although in young women is 60%) and with a progression rate of CIN-3 (pre-cancer) of 22%. CIN-3 only has a 32% chance of regression. CIN-2 and CIN-3 are treated with surgery despite having a different behavior, so we overtreat patients who would not need it because they could solve the lesion. The surgical intervention is called conization, and is based on removing the outermost fragment of the cervix. It is associated to later obstetric problems such as preterm delivery when performed more than once. Biological markers are proteins that can be identified in these lesions. P16 is a protein involved in cell cycle regulation and its overexpression appears in high-risk HPV infections. Ki-67 is a nuclear protein found in all replicating cells. Our work aims to describe the outcome of CIN-2 lesions followed without treatment during 12 months to evaluate regression rates according to p16 and Ki-67 staining status. Patients with first time histologic diagnosis of CIN-2, older than 18 years old, with satisfactory colposcopy, agreed to follow-up every 4 months for at least 2 years, were prospectively recruited. Previous abnormal cytology and high-risk HPV were reported at baseline. p16 and Ki-67 expression were analyzed on CIN-2 biopsies. Regression was defined as CIN1 biopsy or two consecutive negative cytology, persistence as CIN2 biopsy and progression as histologic diagnosis of CIN3. All patients with CIN3 biopsy were treated with cone excision. The rate of spontaneous regression at 12 months was 65.7%, while 7.8% progressed and 26.5% had a persistent disease. Regression was observed in all p16 negative cases and 56.8% of the p16 positive. All Ki-67 negative cases and 59.3% of the Ki-67 positive cases regressed. HSIL previous cytology, HPV-16 and HPV-18 infection were statistically associated to non-regression compared to regression while HPV-negative was associated to regression. Big lesions (more than 50% of the cervix surface), irregular pattern and major colposcòpic changes were related to non regression. Conclusion The high regression rate of CIN-2 supports clinical observation in selected patients. Our data support that CIN-2 patients with negative p16 and Ki-67 are safe to follow conservative management. It also suggests that HPV-negative and non-HSIL patients should follow less strict follow up. Biomarkers predicting CIN2 regression seem to have a great clinical value and could reduce unnecessary cone excisions and associated complications.
Forteza, Valadés Ana. "Validación de la sobreexpresión de la proteína p16 mediante inmunohistoquímica en el diagnóstico histológico de neoplasia intraepitelial de cérvix grado 2 y en la predicción de su capacidad evolutiva." Doctoral thesis, Universitat Autònoma de Barcelona, 2018. http://hdl.handle.net/10803/663821.
Full textIntroduction In the early 70's it was clearly established that the Human Papillomavirus (HPV) is the causative agent of cervical cancer. In addition, its natural history, of about ten years, from infection to the appearance of cancer, is very well studied. These characteristics make cervical cancer an ideal disease to establish prevention programs, both primary and secondary. The preneoplastic lesions of the cervix, suppose a very high number of consultations and reconsultations, generating anxiety to the patients, generally young, that sometimes, must be submitted to surgical interventions. This supposes a high cost for the public health, therefore we must try to be the most efficient, selecting the patients well to follow and treat. Objectives of the study To assess the suitability of the use of the classification in three grades 1 - 2 and 3 of the intraepithelial neoplasms of the cervix (CIN), studying the agreement between pathologists when establishing diagnoses. To study how the agreement between them corrects the p16 Immunohistochemical staining and to evaluate the suitability of the use of the binary classification - high or low grade lesions - for the diagnosis of these same lesions. We will also study if p16 can predict which lesions will evolve worse. Material and method We have collected from our archive 132 cervical biopsies diagnosed between 1999 and 2007 of CIN 2, and we have mixed them with a random sample of 154 more cervical biopsies, with a diagnosis of Negative, CIN 1, CIN 2, CIN 3 or carcinoma. We have reevaluated them by three different pathologists, establishing concordance rates. Subsequently we performed p16 to a representation of the biopsies to re-establish concordance data. Then, we passed a random selection of 50 biopsies stained with HE only to establish the diagnosis based on the binary classification. We have also studied the relationship between the p16 result of the CIN 2 biopsies and the result of the subsequent conization. Results and Discussion The concordance index (Kappa index) between the different pathologists when establishing a diagnosis of small biopsies of the cervix with HE is around 0.40, being lower for the CIN 1 and CIN 2 lesions than for the diagnoses CIN3. With the indiscriminate use of p16 not only does it not improve, but it does get worse, however we do observe a notable improvement in the Kappa index using the binary classification (it reaches a value of 0.75) that improves using p16 together (up to 0, 82). In most cases the CIN 2 biopsies that were positive for p16 present a conization piece with a high-grade lesion (CIN2 +) but not in 100% of the cases, and we also found cases with negative p16 that are followed of a high-grade injury. Conclusions The binary classification of preneoplastic lesions of the cervix improves the interobserver concordance when establishing diagnoses. P16 helps, if used after a training, and is reserved for those doubtful cases. You can not establish diagnoses based only on the result of p16, it is a complement to hematoxylin.
Carrasco, García Miguel Ángel. "Neoplasia Intraepitelial Cervical grado II y III: Estudio morfométrico de sus diferencias y relación con el Virus del Papiloma Humano." Doctoral thesis, Universitat Internacional de Catalunya, 2010. http://hdl.handle.net/10803/9355.
Full textHem estudiat 66 peces quirúrgiques d'exèresi del coll uterí de pacients amb diagnòstic histològic de CIN 2 i 82 de CIN 3. Hem demostrat amb el nostre estudi que la superfície afectada en el coll cervical per CIN 3 és significativament més gran que la de CIN 2, a la vegada que són lesions longitudinalment majors, amb major afectació glandular, major profunditat en l'afectació glandular i major índex mitòtic. També hem pogut demostrar que VPH 16/18 predomina en CIN 3. No hem trobat diferències significatives en quant a la presència de papil·les vasculars en ambdues lesions i tampoc hem trobat relació entre tipus de VPH i àrea afectada per CIN, així com entre tipus de VPH i edat de la pacient.
El propósito de nuestro trabajo es valorar morfométricamente las diferencias existentes entre la Neoplasia Intraepitelial Cervical (CIN) grado 2 y 3, así como el tipo de Virus del Papiloma Humano (VPH) presente, estudiado mediante Hibridación in Situ.
Hemos estudiado 66 piezas quirúrgicas de exéresis del cuello cervical de pacientes con diagnóstico histológico de CIN 2 y 82 de CIN 3. Hemos demostrado con nuestro estudio que la superficie afectada en el cuello cervical por CIN 3 es significativamente mayor que la de CIN 2, a la vez que son lesiones longitudinalmente mayores, con mayor afectación glandular, mayor profundidad en la afectación glandular y mayor índice mitótico. También hemos podido demostrar que VPH 16/18 predomina en CIN 3. No hemos encontrado diferencias significativas en cuanto a la presencia de papilas vasculares en las dos lesiones y tampoco hemos encontrado relación entre tipo de VPH y área afectada por CIN, así como entre tipo de VPH y edad de la paciente.
Westin, Maria Cristina do Amaral 1949. "Expressão das proteínas MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2 e VEGF-A na NIC 3 e no carcinoma invasor do colo do útero = Expression of the proteins MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2 and VEGF-A in the CIN 3 and cervical cancer." [s.n.], 2013. http://repositorio.unicamp.br/jspui/handle/REPOSIP/313599.
Full textTexto em português e inglês
Tese (doutorado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-23T06:30:30Z (GMT). No. of bitstreams: 1 Westin_MariaCristinadoAmaral_D.pdf: 3122088 bytes, checksum: 3d2afed3690cd3566bbb3fe26bb492a3 (MD5) Previous issue date: 2013
Resumo: Introdução: O carcinoma escamoso do colo uterino é precedido pela neoplasia intraepitelial cervical grau 3 (NIC 3). A invasão tumoral envolve a degradação da matriz extracelular e membrana basal do epitélio por enzimas proteolíticas denominadas metaloproteinases (MMPs). Os inibidores teciduais das metaloproteinases (TIMPs) também interferem no processo de invasão. Angiogênese é condição indispensável para a progressão tumoral. Objetivo: Analisar a expressão de MMP-2, MMP-9, MMP-14, TIMP-1, TIMP-2 e VEGF-A na NIC 3 e carcinoma do colo uterino. Sujeito e Métodos: Estudo do tipo comparativo observacional constituído de três grupos:- Grupo 1: 55 casos com diagnóstico de NIC 3, Grupo 2: 30 casos com NIC 3 e carcinoma associados e Grupo 3: 46 casos com carcinoma. A expressão protéica foi pesquisada separadamente nas células tumorais e estromais por reação imunoistoquímica. Para estabelecer a porcentagem de células imunopositivas utilizou-se software morfométrico. Análise Estatística: Aplicou-se o Teste T-pareado ou de Mann-Whitney ou Wilcoxon Signed Rank. Resultados: Em todos os grupos, a expressão tumoral de MMP-14 foi maior que a estromal. Inversamente, a expressão de TIMP-2 foi maior nas células estromais que nas tumorais, em cada grupo diagnóstico. A expressão de MMP-9 foi maior nas células estromais que nas tumorais, com exceção do componente invasor do Grupo 2. A expressão estromal de TIMP-1 foi maior que a tumoral no carcinoma e, ao contrário, sua expressão foi maior nas células tumorais da NIC 3. A expressão de VEGF-A foi maior apenas nas células tumorais da NIC 3. Comparando a expressão dos marcadores entre os grupos, foram encontradas as maiores diferenças entre grupos extremos, ou seja, entre NIC 3 e carcinoma. A expressão de MMP-2 nas células estromais foi maior no componente NIC 3 do Grupo 2 que no NIC 3 do Grupo 1. A expressão de VEGF-A nas células estromais do carcinoma foi maior que nas células estromais da NIC 3. Conclusões: Os resultados deste estudo sugerem que a expressão de TIMP-1 aumenta nas células do estroma e diminui nas células tumorais quando a NIC 3 progride para carcinoma invasor. MMP-9 e TIMP-2 tiveram expressão similar na NIC 3 e no carcinoma, o que limita inferências sobre seu papel na progressão neoplásica. O padrão imunoistoquímico da expressão das MMPs, TIMPs e VEGF-A na NIC 3 e no carcinoma invasivo, quando estas lesões estavam associadas, foi semelhante. A expressão do VEGF-A foi maior nas células tumorais do que nas estromais da NIC 3, porém quando esta lesão progride para carcinoma invasivo sua expressão aumenta nas células do estroma e não se altera nas tumorais. A expressão de MMP-14, MMP-2, TIMP-1 e VEGF-A aumentou com a gravidade da neoplasia
Abstract: Introduction: Squamous cell carcinoma of the cervix is preceded by cervical intraepithelial neoplasia grade 3 (CIN 3). Tumor invasion involves degradation of extracellular matrix and epithelium basement membrane by proteolytic enzymes called metalloproteinases (MMPs). Tissue inhibitors of metalloproteinases (TIMPs) are also involved in the invasion process. Angiogenesis is a prerequisite for tumor progression. Objective: To analyze the expression of MMP-2, MMP-9 and MMP-14, TIMP-1, TIMP-2 and VEGF-A in CIN 3 and invasive carcinoma. Subject and Methods: This comparative observational study was consists of three groups: Group 1: 55 cases diagnosed with CIN 3, Group 2: 30 cases with CIN 3 associated with invasive carcinoma and Group 3: 46 cases with invasive carcinoma. Protein expression was investigated separately in tumor and stromal cells by immunohistochemistry and evaluated by the percentage of cells positive for immunostaining using morphometric software. Statistical Analysis: Was performed applying paired t-test or Mann-Whitney or Wilcoxon Signed Rank. Results: In each diagnostic group, expression markers were significantly higher: MMP-14 in tumor cells, and TIMP-2 in stromal cells; also MMP-9 expression was significantly higher in stromal cells, except in invasive component of group 2, and TIMP-1 had significantly higher expression in stromal cells of invasive carcinoma and in tumor cells of CIN 3. VEGF-A expression was significantly higher only in tumor cells CIN 3. Comparing the expression of markers between groups, two by two, we find the greatest differences between the extreme groups, i.e. between invasive carcinoma and CIN 3. The expression of MMP-2 was significantly greater in the stromal component CIN 3 in group 2 than in CIN 3 only. The expression of VEGF-A was significantly higher in the group stromal cell carcinoma when compared to stromal cells CIN 3. Conclusions: The results of this study suggest that the expression of TIMP-1 increases in the stromal cells and decreases in tumor cells when CIN 3 progresses to invasive carcinoma. MMP-9 and TIMP-2 had similar expression in CIN 3 and invasive carcinoma, which limits inferences about its role in neoplastic progression. The immunohistochemical pattern of expression of MMPs, TIMPs and VEGF-A in CIN 3 and invasive carcinoma, as these lesions were associated, was similar. The expression of VEGF-A was higher in tumor cells than in stromal cells in CIN 3, but when the lesion progresses to invasive carcinoma its expression increases in the stromal cells and the tumor cells does not change. The expression of MMP-14, MMP-2, TIMP-1 and VEGF-A was increased with the severity of the neoplasia
Doutorado
Oncologia Ginecológica e Mamária
Doutora em Ciências da Saúde
Pita, César. "CineScrúpulos (Año 1. Número 2. Abril de 2013)." Universidad Peruana de Ciencias Aplicadas (UPC), 2013. http://hdl.handle.net/10757/625039.
Full textLa presente edición de Cinescrúpulos se centra en la obra de Stanley Kubrick, excéntrico y extraño, alejado de los reflectores en los últimos años de su vida pero entregado en cuerpo y alma al entorno familiar. El director legó una filmografía del crecimiento, del descubrimiento, del enaltecimiento de la experimentación, del regocijo que origina evitar los formulismos del género, de encontrar la independencia tras haber flirteado con el monstruo corporativo, de no hacerle ascos al terror o al erotismo, de jugar cada una de sus piezas con la maestría del ajedrecista nato que era. También nos damos un tiempo para descubrir los vínculos que existen entre el cine de Charles Chaplin y la construcción de personajes y narrativas que han encumbrado a Pixar como una de las opciones más inteligentes en el terreno de los dibujos animados de los últimos años. Y como broche de oro, una pregunta válida: Francisco Lombardi, nuestro cineasta con la mayor cantidad de títulos estrenados en salas, ¿estará construyendo un cine de género en el Perú o apunta más bien hacia otro lado?.
Yates, Thomas E. "Can we out-walk the type 2 diabetes mellitus epidemic?" Thesis, Loughborough University, 2008. https://dspace.lboro.ac.uk/2134/8077.
Full textDavaine, Tristan. "Catch me if you can - En studie om operativ risk i svenska försäkringsföretag." Thesis, Linnéuniversitetet, Institutionen för ekonomistyrning och logistik (ELO), 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-76609.
Full textBackground: Operational risk is a notion that has gained a lot of notoriety due to a number of scandals and bankruptcies within the financial sector. Every Swedish insurance company is obliged to manage its operational risks, and due to the impossibility of normalizing its specific content, it is up to the companies themselves to judge its extent. Many efforts have been made to conceptualize and explain this “fear category”, an effort that in many respects still lacks in consensus. Purpose: The purpose of this study is to increase the knowledge of what constitutes operational risk, from the perspective of Swedish insurance companies, and the way in which a particular view affects the risk management process. Methods: This study has been conducted in two parts. The first part constitutes a cross-sectional study, which has further been expanded on by conducting a multiple case study, encompassing two insurance companies. Conclusion: This study shows that there are many interpretations of operational risk, ranging from very simple to very complex. This study also shows that some companies do not manage risks based on the concepts of “operational risk”, but from a pragmatic approach towards the business, meaning that some of the foundational good practices are not applied. However, this is mitigated by an increased understanding of the business, as well as the application of methods not necessarily associated with risk management.
Paiva, Melissa. "I can explain! understanding perceptions of eyewitnesses as a function of type of explanation and inconsistent confidence statements /." View thesis online, 2009. http://docs.rwu.edu/psych_thesis/2/.
Full textCesur, Halil. "Development Of Cubic Boron Nitride (cbn) Coating Process For Cutting Tools." Master's thesis, METU, 2009. http://etd.lib.metu.edu.tr/upload/2/12610640/index.pdf.
Full text#8217
s market conditions, higher tool life and durable cutting tools which can stand high cutting speeds are required in chip removal process. In order to improve the performance of cutting tools, coatings are employed extensively. Cubic boron nitride (cBN) is a new kind of coating material for cutting tools due to its outstanding properties and testing of cBN as a hard coating for machining have been increasing in recent years. However, there are some challenges such as compressive residual stress, poor adhesion and limiting coating thickness during the deposition of cBN on substrates. In this study, cubic boron nitride (cBN) coatings are formed on cutting tools from hexagonal boron nitride (hBN) target plates. For this purpose, a physical vapor deposition (PVD) system is utilized. PVD system works on magnetron sputtering technique in which material transfer takes place from target plate to substrate surface. Firstly, cBN coatings are deposited on steel and silicon wafer substrates for measurements and analyses. Compositional, structural and mechanical measurements and analysis are performed for the characterization of coatings. Next, several types of cutting tools are coated by cBN and the effects of cBN coatings on cutting performance are investigated. Finally, it can be said that cubic boron nitride coatings are successfully formed on substrates and the improvement of wear resistance and machining performance of cBN coated cutting tools are observed.
Lahiouel, Rachid. "Evolution du réseau Kondo en fonction de l'hybridation : les systèmes CeIn(Ag,Cu)2 et Ce(Ge,Si)2." Grenoble 1, 1987. http://www.theses.fr/1987GRE10054.
Full textBooks on the topic "CIN 2"
L'immaturità psico-affettiva e matrimonio canonico (can. 1095, 2-3 CIC). Città del Vaticano: Libreria editrice vaticana, 2009.
Find full textliang, Ma. Xin gai nian ying yu 2 ci hui chang xiao ji yi. Bei jing: Zhong guo shui li shui dian chu ban she, 2011.
Find full textXin gai nian ying yu 2 dan ci MP3 xun huan ting. Bei jing: Zhong guo shui li shui dian chu ban she, 2009.
Find full textArshad, Hang Tuah. Vokabulari Melayu-Cina: Bahagian 1 & 2. Petaling Jaya, Selangor, Malaysia]: Meoral Pub. House, 2009.
Find full textBankers, Chartered Institute of. CIB practice & revision kit: Stage 2. London: BPP, 1990.
Find full textBook chapters on the topic "CIN 2"
McNeill, Patrick. "Accidents can Happen." In Society Today 2, 126–28. London: Macmillan Education UK, 1991. http://dx.doi.org/10.1007/978-1-349-12065-9_42.
Full textArya, Ali. "Introduction." In Anyone Can Code, 3–19. First edition. | Boca Raton : CRC Press, 2020.: Chapman and Hall/CRC, 2020. http://dx.doi.org/10.1201/9780429244421-2.
Full textDomènech, Conxita, Andrés Lema-Hincapié, and Javier Muñoz-Basols. "La Huerta de España." In Saberes con sabor, 18–37. New York : Routledge, 2020.: Routledge, 2020. http://dx.doi.org/10.4324/9780429433597-2.
Full textChambers, Robert. "CHAPTER 2: Biases and blind spots." In Can We Know Better?, 27–56. The Schumacher Centre, Bourton on Dunsmore, Rugby, Warwickshire, CV23 9QZ, UK: Practical Action Publishing Ltd, 2017. http://dx.doi.org/10.3362/9781780449449.002.
Full textCrosby, Gilmore. "Leadership." In Leadership Can Be Learned, 3–4. Boca Raton, FL : CRC Press, 2018.: Productivity Press, 2017. http://dx.doi.org/10.4324/9781315099293-2.
Full textLeo, Bottaryt. "No One Does It Alone, So Why Should You?" In What Anyone Can Do, 1–12. New York, NY : Taylor & Francis, [2018]: Routledge, 2018. http://dx.doi.org/10.4324/9781315151298-2.
Full textConnelly, Philip W., Graham F. Maguire, and J. Alick Little. "Familial Chylomicronemia Due to Mutations in Apolipoprotein CII: Apolipoprotein CII-Toronto and Apolipoprotein CII-St. Michael." In Human Apolipoprotein Mutants 2, 121–26. Boston, MA: Springer US, 1989. http://dx.doi.org/10.1007/978-1-4615-9549-6_15.
Full textPalmer, Julia E., and John A. Tidy. "Chapter 2 Management of cervical intraepithelial neoplasia (CIN)." In Vaccines for the Prevention of Cervical Cancer. Oxford University Press, 2008. http://dx.doi.org/10.1093/med/9780199543458.003.0002.
Full textStöver, Bernd. "2. «Langley» als Institution." In CIA, 15–32. Verlag C.H.BECK oHG, 2017. http://dx.doi.org/10.17104/9783406704116-15.
Full text"Introduction to Part 2." In Quasi-Static State Analysis of Differential, Difference, Integral, and Gradient Systems, 85–87. Providence, Rhode Island: American Mathematical Society, 2010. http://dx.doi.org/10.1090/cln/021/05.
Full textConference papers on the topic "CIN 2"
Bark, V., A. Mondal, and M. Hampl. "Regressionsraten von CIN 2/CIN 3 bei Frauen unter 25 Jahren." In Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). © 2020. Thieme. All rights reserved., 2020. http://dx.doi.org/10.1055/s-0040-1718120.
Full textPaspalj, V., S. Pils, R. Ristl, and E. Joura. "Metaanalyse zur HPV-Impfung nach Konisation und Rezidivrisiko für CIN 2+." In Kongressabstracts zur Wissenschaftlichen Tagung der Arbeitsgemeinschaft für gynäkologische Onkologie (AGO) der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG). Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1681993.
Full textSiegler, E., O. Lavie, L. Mackuli, L. Ostrovsky, N. Kugelman, and Y. Segev. "EP402 Low Risk HPV types in CIN 2–3 and in invasive cervical cancer patients." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.461.
Full textKim, Mi Kyung, Sang Hoon Lee, Kyung-Jin Min, and Jae Kwan Lee. "Abstract 1888: HPV viral load and alcohol synergize to increase the risk of cervical intraepithelial neoplasia (CIN)1 in HPV positive women: Korean HPV Cohort Study." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-1888.
Full textHillemanns, P., KU Petry, G. Böhmer, M. Jentschke, L. Wölber, I. Skjørestad, A. Frederiksen, and M. Axelsen. "P22 An exploratory safety and immunogenicity study of human papillomavirus (HPV16+) immunotherapy VB10.16 in women with high grade cervical intraepithelial neoplasia (HSIL; CIN 2/3)." In ESGO Annual Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-esgo.85.
Full textPark, JS, SJ Lee, SY Hur, TJ Kim, SR Hong, JK Lee, CH Cho, YS Suh, JW Woo, and YC Sung. "27 GX-188E, A therapeutic HPV vaccine, in combination with imiquimod or IL-7-HYFC for treatment of HPV-16 or HPV-18 related cin 3: results from phase 2 study." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.27.
Full textBlayney, Douglas W., Lan Huang, and Ramon W. Mohanlal. "Abstract OT-06-02: Protective-2 (bpi-2358-106): A confirmatory trial to demonstrate superiority of the plinabulin+pegfilgrastim (plin/peg) combination versus standard of care pegfilgrastim for the prevention of chemotherapy-induced neutropenia (cin) in breast cancer (bc) patients (pts)." In Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.sabcs20-ot-06-02.
Full textMeyer, M., I. Schellenberg, B. Hofmann, and G. Vogel. "A GENETIC VARIANT OP PLATELET MEMBRANE GLYCOPROTEIN lb ASSOCIATED WITH A MILD BLEEDING DISORDER." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643510.
Full textHillemanns, Peter, Karl Ulrich Petry, Linn Woelber, Gerd Böhmer, Elisabeth Stubsrud, Irene Skjørestad, Karoline Schjetne, Agnete Fredriksen, and Mads Axelsen. "Abstract CT209: Safety, efficacy and immunogenicity of VB10.16, a therapeutic DNA vaccine targeting human papillomavirus (HPV) 16 E6 and E7 proteins for high grade cervical intraepithelial neoplasia (CIN 2/3): 6-month data from an exploratory open-label phase I/2a trial." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-ct209.
Full textHillemanns, Peter, Karl Ulrich Petry, Linn Woelber, Gerd Böhmer, Elisabeth Stubsrud, Irene Skjørestad, Karoline Schjetne, Agnete Fredriksen, and Mads Axelsen. "Abstract CT209: Safety, efficacy and immunogenicity of VB10.16, a therapeutic DNA vaccine targeting human papillomavirus (HPV) 16 E6 and E7 proteins for high grade cervical intraepithelial neoplasia (CIN 2/3): 6-month data from an exploratory open-label phase I/2a trial." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-ct209.
Full textReports on the topic "CIN 2"
Eugene J Fine, Eugene J. Fine. Part 2: Can low carbohydrate ketogenic diets inhibit cancers? Experiment, July 2016. http://dx.doi.org/10.18258/7344.
Full textLowell, Eini C., Daniel J. Parrent, Robert C. Deering, Dan Bihn, and Dennis R. Becker. Community biomass handbook. Volume 2: Alaska, where woody biomass can work. Portland, OR: U.S. Department of Agriculture, Forest Service, Pacific Northwest Research Station, 2015. http://dx.doi.org/10.2737/pnw-gtr-920.
Full textAragon, K., and S. Denman. NWC (Nuclear Weapon Complex) CIM file header specification: Version 2. 0. Office of Scientific and Technical Information (OSTI), April 1990. http://dx.doi.org/10.2172/6799136.
Full textEckman, Stephanie, Joe Eyerman, and Dorota Temple. Unmanned Aircraft Systems Can Improve Survey Data Collection. RTI Press, June 2018. http://dx.doi.org/10.3768/rtipress.2018.rb.0018.1806.
Full textDr. Ingrid Eisgruber. Manufacturable CuIn(Ga)Se{sub 2}-based solar cells via development of co-sputtered CuInSe{sub 2} absorber layers. Office of Scientific and Technical Information (OSTI), March 1999. http://dx.doi.org/10.2172/764593.
Full textRus, Daniela, Erik Demaine, Ron Fearing, Ali Javey, Rob Wood, Vijay Kumar, and Mark Yim. Programmable Matter Creating Systems that Can Think, Talk, and Morph Autonomously. Phase 2. Fort Belvoir, VA: Defense Technical Information Center, September 2011. http://dx.doi.org/10.21236/ada584792.
Full textSmith, M. E. Phase 2 Can-in-Canister Cold Pour Tests for the Plutonium Immobilization Project. Office of Scientific and Technical Information (OSTI), December 2000. http://dx.doi.org/10.2172/768682.
Full textEisgruber, I. L., J. R. Engel, R. Treece, and R. Hollingsworth. In-situ sensors for process control of CuIn(Ga)Se{sub 2}: Phase 2 Annual Report, February 1999 - February 2000. Office of Scientific and Technical Information (OSTI), June 2000. http://dx.doi.org/10.2172/757165.
Full textTrowbridge, L. D. Estimation of Flammability Limits of Selected Fluorocarbons with F(sub 2) and CIF(sub3). Office of Scientific and Technical Information (OSTI), September 1999. http://dx.doi.org/10.2172/12455.
Full textDesimone, David J., and Duc Ta Vo. Nondestructive Analysis of MET-5 Paint Can at TA35 Building 2 A-Wing Vault. Office of Scientific and Technical Information (OSTI), November 2016. http://dx.doi.org/10.2172/1331254.
Full text